Entropion

Entropion

  • Overview
  • Appointments
  • Symptoms
  • Diagnosis
  • Treatment
  • Locations
  • Doctors

    • What is entropion?

    Entropion is a condition in which your lower eyelid turns inward, rubbing against your eye. It usually is caused by a spasm or weakening of the muscles surrounding the eyelid. Entropion occurs most commonly as a result of aging. By age, the tendons and muscles that hold your eyelid taut against your eye stretches out and your eyelid starts to turn in. Previous surgeries, burns, trauma, infection, inflammation and birth defects are other causes of entropion. 

    What Is Entropion?

    Appointment Information

    To schedule an appointment, please call 734-764-5106.

    What are the symptoms of entropion?

    Symptoms include: 

    • Turning in of the eyelids
    • Redness
    • Irritation and pain in the eye
    • Sensitivity to light and wind
    • Excessive tearing

    The symptoms described above may not necessarily mean that you have entropion. However, if you experience one or more of these symptoms, contact your ophthalmologist for a complete exam.

    How is entropion diagnosed?

    Entropion is diagnosed with an eye examination. During the examination, your doctor will evaluate your eyelid and the surrounding tissue to find the right treatment for you.

    What is the treatment for entropion?

    Treatment involves surgery, which restores the eyelid to its normal position, protects the eye, and improves symptoms.

    Locations
    • Oculoplastic Surgery Clinic | Kellogg Eye Center 1000 Wall St
      Elevator B Floor 3
      Ann Arbor, MI 48105-1912       Get Directions
    • Ophthalmology Clinic | Canton Health Center 1051 N Canton Center Rd
      Canton, MI 48187-5097       Get Directions

    Doctors

     Search for a U-M Health doctor     Elaine Downie, MD

    Elaine Downie, MD

    Clinical Assistant Professor

    Ophthalmology, Oculoplastics Ophthalmology

    Angela Elam, MD

    Angela Renee Elam, MD, MPH

    Assistant Professor

    Ophthalmology, Oculoplastics Ophthalmology

    News & Stories
    woman with dog smiling
    Health Lab

    Patient with retinitis pigmentosa receives new hope at Kellogg’s low vision clinic

    Retinitis pigmentosa can lead to vision loss, but DNA testing, inherited retinal disease research and AI glasses offer new hope.
         presentation on stage with slideshow up
    Health Lab

    Medical students develop novel technological solutions for unmet patient needs

    University of Michigan medical students showcased AI-driven healthcare innovation projects focused on melanoma support, transplant recovery and primary care access.
         Close up of a hazel green eye
    Health Lab

    A new clue for aging eyes

    Struggling to read more than six lines on an eye chart with fading letters may serve as a visual “yellow light” for older adults—raising red flags that routine exams sometimes fail to detect.
         Susan Lane, wearing glasses and a dress with blue, red, black, and purple brushstroke designs, stands next to Alan Sugar, who is wearing glasses and a grey blazer with a blue tie. They are standing in a shaded courtyard area with shrubs and a brick wall behind them.
    Philanthropy News

    Susan J. Lane: Gratitude and Giving

    Susan Lane has made a transformational gift to the Department of Ophthalmology and Visual Sciences at Michigan Medicine to support corneal research and patient education.
         person putting contacts on up close to mirror
    Health Lab

    Improving eye comfort in patients who wear contact lenses

    Common difficulties include persistent discomfort, dry eyes, small bumps on the eye surface called corneal infiltrates and inflammation of the upper eyelid. Karen DeLoss, clinical associate professor of ophthalmology and visual sciences at U-M Health discusses how contact lenses work, types of lenses available and treatment options for patients who struggle with wearing them.
         eye drawing blue yellow highlight
    Health Lab

    Adult stem cells show therapeutic promise in treating vision loss from macular degeneration

    Researchers used retinal pigment epithelial stem cells derived from adult postmortem eye tissue in a phase 1/2a clinical trial. This is the first treatment to show promise for age-related macular degeneration or AMD.